Beginning Cash: The amount of cash reported by the company on its previous statement.
Viridian Therapeutics, Inc. (VRDN) had Beginning Cash of $102.83M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.30M |
|
$-269.95M |
|
-- |
|
$0.30M |
|
$299.34M |
|
$-299.04M |
|
$29.09M |
|
$-269.95M |
|
$-269.95M |
|
$-269.95M |
|
$-269.95M |
|
$-269.95M |
|
$-269.95M |
|
$-299.04M |
|
$-314.15M |
|
67.89M |
|
67.89M |
|
$-3.07 |
|
$-3.07 |
|
| Balance Sheet Financials | |
$738.46M |
|
$1.24M |
|
$3.94M |
|
$742.40M |
|
$47.87M |
|
$20.58M |
|
$22.89M |
|
$70.76M |
|
$482.75M |
|
$671.64M |
|
$671.64M |
|
80.99M |
|
| Cash Flow Statement Financials | |
$-232.32M |
|
$-228.65M |
|
$457.74M |
|
|
Beginning Cash |
$102.83M |
$99.59M |
|
$-3.23M |
|
$42.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.43 |
|
-- |
|
-- |
|
0.03 |
|
0.03 |
|
100.00% |
|
-99018.22% |
|
-99018.22% |
|
-104023.20% |
|
-89387.09% |
|
-89387.09% |
|
$-232.83M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-55.92% |
|
-40.19% |
|
-36.36% |
|
-39.00% |
|
$8.29 |
|
$-3.43 |
|
$-3.42 |
|